BE871584A - Preparations pharmaceutiques - Google Patents
Preparations pharmaceutiquesInfo
- Publication number
- BE871584A BE871584A BE191383A BE191383A BE871584A BE 871584 A BE871584 A BE 871584A BE 191383 A BE191383 A BE 191383A BE 191383 A BE191383 A BE 191383A BE 871584 A BE871584 A BE 871584A
- Authority
- BE
- Belgium
- Prior art keywords
- pharmaceutical preparations
- preparations
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LU78408 | 1977-10-28 | ||
LU78407 | 1977-10-28 | ||
CH546578A CH642944A5 (en) | 1978-05-19 | 1978-05-19 | Urea derivatives |
CH546678A CH639846A5 (en) | 1978-05-19 | 1978-05-19 | Pharmaceutical preparations having antiandrogenic action, containing urea derivatives or hydantoin derivatives |
CH940778A CH644850A5 (en) | 1977-10-28 | 1978-09-07 | Pharmaceutical preparations containing urea derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BE871584A true BE871584A (fr) | 1979-04-27 |
Family
ID=27509239
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE191383A BE871584A (fr) | 1977-10-28 | 1978-10-27 | Preparations pharmaceutiques |
Country Status (15)
Country | Link |
---|---|
US (1) | US4234736A (de) |
JP (1) | JPS5473754A (de) |
AU (2) | AU522796B2 (de) |
BE (1) | BE871584A (de) |
BR (1) | BR7807115A (de) |
CA (2) | CA1138334A (de) |
DE (1) | DE2846945A1 (de) |
DK (1) | DK481778A (de) |
FR (1) | FR2407205A1 (de) |
GB (2) | GB2087870B (de) |
IL (1) | IL55774A (de) |
IT (1) | IT1100904B (de) |
NL (1) | NL7810562A (de) |
NZ (1) | NZ188720A (de) |
SE (2) | SE433304B (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MC1220A1 (fr) * | 1977-10-28 | 1979-07-20 | Hoffmann La Roche | Nouveaux derives d'imidazolidine |
FI801184A (fi) * | 1979-04-24 | 1980-10-25 | Hoffmann La Roche | Foerfarande foer framstaellning av imidazolidinderivat |
EP0091596B1 (de) * | 1982-04-08 | 1991-09-11 | Shell Internationale Researchmaatschappij B.V. | Neue Hydantoine, ihre Herstellung und Verwendung |
JP2791156B2 (ja) * | 1988-08-23 | 1998-08-27 | ザ ヌトラスウィート カンパニー | 強力甘味料としての置換アリール尿素 |
FR2656302B1 (fr) * | 1989-12-22 | 1992-05-07 | Roussel Uclaf | Nouveau procede de preparation de l'anandron et derives de l'anandron. |
US5411981A (en) * | 1991-01-09 | 1995-05-02 | Roussel Uclaf | Phenylimidazolidines having antiandrogenic activity |
USRE35956E (en) * | 1991-01-09 | 1998-11-10 | Roussel Uclaf | Phenylimidazolidines having antiandrogenic activity |
FR2671348B1 (fr) * | 1991-01-09 | 1993-03-26 | Roussel Uclaf | Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant. |
US5670641A (en) * | 1995-06-02 | 1997-09-23 | American Cyanamid Company | 3-(3-aryloxyphenyl)-1-(substituted methyl)-S-triazine-2,4,6-oxo or thiotrione herbicidal agents |
CA2413417A1 (en) * | 2000-06-28 | 2002-01-03 | Bristol-Myers Squibb Company | Selective androgen receptor modulators and methods for their identification, design and use |
US7001911B2 (en) | 2000-06-28 | 2006-02-21 | Bristol-Myers Squibb Company | Fused cyclic modulators of nuclear hormone receptor function |
US20040077605A1 (en) | 2001-06-20 | 2004-04-22 | Salvati Mark E. | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
US6953679B2 (en) | 2000-09-19 | 2005-10-11 | Bristol-Myers Squibb Company | Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof |
EP1854798A3 (de) | 2000-09-19 | 2007-11-28 | Bristol-Myers Squibb Company | Kondensierte heterozyklische Succinimid-Verbindungen und Analoga daraus, Modulatoren der nuklearen Hormonrezeptorfunktion |
US20040087548A1 (en) | 2001-02-27 | 2004-05-06 | Salvati Mark E. | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
US7087636B2 (en) | 2001-12-19 | 2006-08-08 | Bristol-Myers Squibb Company | Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
CA2550447A1 (en) * | 2003-12-19 | 2005-07-07 | The Regents Of The University Of California | Methods and materials for assessing prostate cancer therapies |
NZ550102A (en) * | 2004-02-24 | 2010-10-29 | Univ California | Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives) |
US7709517B2 (en) | 2005-05-13 | 2010-05-04 | The Regents Of The University Of California | Diarylhydantoin compounds |
PT2656841T (pt) | 2006-03-27 | 2016-09-28 | Univ California | Modulador do recetor de androgénios para o tratamento de cancro da próstata e doenças associadas ao recetor de androgénios |
KR101600230B1 (ko) | 2006-03-29 | 2016-03-04 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 디아릴티오히단토인 화합물 |
EP2220050A2 (de) | 2007-10-26 | 2010-08-25 | The Regents Of The University Of California | Diarylhydantoinverbindungen als androgenrezeptormodulatoren |
ES2668380T3 (es) | 2010-02-16 | 2018-05-17 | Aragon Pharmaceuticals, Inc. | Moduladores de receptores de andrógenos y sus usos |
SI3305285T1 (sl) | 2012-09-26 | 2021-03-31 | Aragon Pharmaceuticals, Inc. | Anti-androgeni za zdravljenje proti kastraciji odpornega ne-metastatskega raka |
JOP20200097A1 (ar) | 2013-01-15 | 2017-06-16 | Aragon Pharmaceuticals Inc | معدل مستقبل أندروجين واستخداماته |
TWI726969B (zh) | 2016-01-11 | 2021-05-11 | 比利時商健生藥品公司 | 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物 |
JOP20200076A1 (ar) | 2017-10-16 | 2020-04-30 | Aragon Pharmaceuticals Inc | مضادات أندروجين لعلاج سرطان البروستاتا غير النقيلي المقاوم للاستئصال |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE629779A (de) * | ||||
US3134663A (en) * | 1957-07-23 | 1964-05-26 | Geigy Chem Corp | Herbicidal composition and method employing hydantoins |
GB997037A (en) | 1962-03-19 | 1965-06-30 | Ici Ltd | New hydrantoin derivatives |
IL31416A0 (en) | 1968-02-19 | 1969-03-27 | Bayer Ag | 5-imino-2-oxo-imidazolidines,their preparation and use as herbicides |
NL6904420A (de) * | 1968-03-28 | 1969-09-30 | ||
DK123717B (da) * | 1968-11-25 | 1972-07-24 | Sumitomo Chemical Co | 3-(3',5'-Dihalogenphenyl)-imidazolidin-2,4-dionderivater med mirobicid virkning. |
US3676456A (en) * | 1970-02-27 | 1972-07-11 | Ciba Geigy Corp | Derivatives of 3-aryl-5-alkylhydantoins |
JPS5136332B1 (de) * | 1970-12-09 | 1976-10-07 | ||
US4044021A (en) * | 1971-10-21 | 1977-08-23 | American Cyanamid Company | Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism |
IL45459A (en) * | 1973-09-03 | 1978-01-31 | Ciba Geigy Ag | 1-(dichlorofluoromethylthio)-3-phenyl-imidazolidine-2,4-dione derivatives their preparation and their use as bactericides and fungicides |
FR2329276A1 (fr) * | 1975-10-29 | 1977-05-27 | Roussel Uclaf | Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant |
-
1978
- 1978-10-20 IL IL55774A patent/IL55774A/xx unknown
- 1978-10-20 CA CA000313827A patent/CA1138334A/en not_active Expired
- 1978-10-23 NL NL7810562A patent/NL7810562A/xx not_active Application Discontinuation
- 1978-10-23 AU AU40962/78A patent/AU522796B2/en not_active Expired
- 1978-10-24 US US05/954,071 patent/US4234736A/en not_active Expired - Lifetime
- 1978-10-24 NZ NZ188720A patent/NZ188720A/en unknown
- 1978-10-25 FR FR7830328A patent/FR2407205A1/fr active Granted
- 1978-10-27 GB GB8118700A patent/GB2087870B/en not_active Expired
- 1978-10-27 BR BR7807115A patent/BR7807115A/pt unknown
- 1978-10-27 SE SE7811193A patent/SE433304B/xx not_active IP Right Cessation
- 1978-10-27 IT IT29207/78A patent/IT1100904B/it active
- 1978-10-27 DK DK481778A patent/DK481778A/da not_active Application Discontinuation
- 1978-10-27 JP JP13177378A patent/JPS5473754A/ja active Pending
- 1978-10-27 GB GB7842246A patent/GB2008101B/en not_active Expired
- 1978-10-27 BE BE191383A patent/BE871584A/xx not_active IP Right Cessation
- 1978-10-27 DE DE19782846945 patent/DE2846945A1/de not_active Ceased
-
1982
- 1982-03-02 AU AU81051/82A patent/AU551161B2/en not_active Expired
- 1982-04-01 SE SE8202106A patent/SE8202106L/xx not_active Application Discontinuation
- 1982-04-08 CA CA000400814A patent/CA1137091A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
AU4096278A (en) | 1980-05-01 |
GB2087870A (en) | 1982-06-03 |
DK481778A (da) | 1979-04-29 |
GB2087870B (en) | 1982-11-10 |
IT7829207A0 (it) | 1978-10-27 |
NL7810562A (nl) | 1979-05-02 |
FR2407205B1 (de) | 1982-12-31 |
AU8105182A (en) | 1982-07-08 |
CA1137091A (en) | 1982-12-07 |
GB2008101A (en) | 1979-05-31 |
AU551161B2 (en) | 1986-04-17 |
IL55774A (en) | 1982-04-30 |
SE7811193L (sv) | 1979-04-29 |
US4234736A (en) | 1980-11-18 |
CA1138334A (en) | 1982-12-28 |
DE2846945A1 (de) | 1979-05-03 |
SE433304B (sv) | 1984-05-21 |
IT1100904B (it) | 1985-09-28 |
BR7807115A (pt) | 1979-05-15 |
FR2407205A1 (fr) | 1979-05-25 |
NZ188720A (en) | 1984-12-14 |
JPS5473754A (en) | 1979-06-13 |
SE8202106L (sv) | 1982-04-01 |
GB2008101B (en) | 1982-09-08 |
IL55774A0 (en) | 1978-12-17 |
AU522796B2 (en) | 1982-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE871584A (fr) | Preparations pharmaceutiques | |
NO801863L (no) | Farmasoeytiske preparater. | |
SE7803527L (sv) | Lekemedelsdosenhet | |
ZA783480B (en) | New pharmaceutical preparations | |
FI800910A (fi) | Farmaceutiskt anvaendbara 4-amino-3-kinolinkarboxylsyror och -estrar | |
FI803767L (fi) | Cortikosteroid innehaollande farmaceutiska blandningar | |
BE864359A (fr) | Compositions pharmaceutiques antioestrogenes | |
SE7809373L (sv) | Farmaceutiskt anvendbara 5-hydroxi-1h-imidazol-4-karboxamidderivat | |
IT1095377B (it) | Composizione farmaceutica | |
NL188645C (nl) | 1-azaxanthon-3-carbonzuurverbindingen en farmaceutische preparaten die deze verbindingen bevatten. | |
NL7806573A (nl) | Preparaten met geneeskundige werkzaamheid. | |
NL7903769A (nl) | Di-o-n-alkylglycerolderivaten en farmaceutische preparaten daarvan. | |
FI790404A (fi) | Farmaceutiska sammansaettningar | |
NL7801921A (nl) | Farmaceutische preparaten. | |
BE863710A (nl) | Pesticide-preparaten | |
NL7809626A (nl) | Therapeutische preparaat. | |
BE870265A (fr) | Compositions pharmaceutiques anti-inflammatoires | |
MC1372A1 (fr) | Preparations pharmaceutiques | |
MC1371A1 (fr) | Preparations pharmaceutiques | |
BE853569A (nl) | Medicinale preparaten | |
FI783049A (fi) | Farmaceutiskt aktiva(omega-aminoalkoxi)dibenzyler | |
NL184896C (nl) | Pyranochinolinonderivaten en gevormde farmaceutische preparaten die deze bevatten. | |
NL7805158A (nl) | Farmaceutisch preparaat. | |
DD128671A5 (de) | Pharmazeutische mittel | |
SE7600480L (sv) | Farmaceutiskt anvendbara 2-aminoacetamido-alfa-fenylbensylidenaminoalk |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: F. HOFFMANN-LA ROCHE & CIE S.A. Effective date: 19871031 |